United States of America, ex rel. v. Bayer AG

CourtDistrict Court, D. Rhode Island
DecidedOctober 21, 2019
Docket1:14-cv-00031
StatusUnknown

This text of United States of America, ex rel. v. Bayer AG (United States of America, ex rel. v. Bayer AG) is published on Counsel Stack Legal Research, covering District Court, D. Rhode Island primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States of America, ex rel. v. Bayer AG, (D.R.I. 2019).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF RHODE ISLAND

___________________________________ ) UNITED STATES OF AMERICA et al., ) ex rel. JOHN R. BORZILLERI, M.D., ) ) Plaintiffs, ) ) v. ) C.A. No. 14-031 WES ) BAYER HEALTHCARE ) PHARMACEUTICALS, INC., et al. ) ) Defendants. ) ___________________________________)

MEMORANDUM OF DECISION WILLIAM E. SMITH, Chief Judge. This case is before the Court on three motions: the United States’ Motion to Dismiss the Complaint Pursuant to § 3730(c)(2)(A) of the False Claims Act, ECF No. 166; Manufacturer Defendants’ Joint Motion to Dismiss the Second Amended Complaint, ECF No. 157; and the Pharmacy Benefit Manager Defendants’ Joint Motion To Dismiss Relator’s Second Amended Complaint, ECF No. 163. After careful consideration, the Court issued a text order on September 27, 20191, GRANTING the United States’ Motion to Dismiss and DENYING both of Defendants’ Motions to Dismiss as moot. This memo explains the reasoning behind that order.

1 The Court subsequently issued an amended text order on October 1, 2019. In this qui tam action, relator John R. Borzilleri alleges that pharmaceutical manufacturers and “Pharmacy Benefit Managers” schemed to defraud Medicare Part D, a federal prescription-drug

program, in violation of the False Claims Act (“FCA”), 31 U.S.C. § 3729 et seq., and various state laws.2 Relator’s Second Amended Compl. (“SAC”), ECF No. 95. The United States (“the Government”) declined to intervene in this action and now moves for its dismissal. United States’ Mot. to Dismiss the Complaint (“Gov’t Mot. To Dismiss”), ECF No. 166. Borzilleri also filed an almost identical action in the United States District Court for the Southern District of New York. United States ex rel Borzilleri v. AbbVie, Inc., No. 15-CV-7881 (JMF), 2019 WL 3203000 (S.D.N.Y. July 16, 2019). In that action, Judge Furman granted the Government’s motion and dismissed all of Borzilleri’s FCA claims. Id. at *3. This Court agrees with Judge Furman’s well-reasoned opinion.

The FCA is structured to allow private plaintiffs to bring a civil action on behalf of the United States, but also to allow the Government substantial control over these actions. See 31 U.S.C. § 3730(b). Specifically, the Government has the right to “dismiss the action notwithstanding the objections of the person initiating the action if the person has been notified by the Government of

2 For a more detailed recitation of the facts and procedural history, see the Manufacturer Defendants’ Joint Motion to Dismiss. ECF No. 157, p.3-10. the filing of the motion and the court has provided the person with an opportunity for a hearing on the motion.” 31 U.S.C. § 3730(c)(2)(A). However, the statute does not explicitly state what

standard courts should use to review the Government’s motion to dismiss an action under the FCA. The courts that have addressed this issue are split on whether the Government must demonstrate a “rational relation” between its reasons for dismissal and a legitimate government interest, or whether the Government has essentially “unfettered” discretion to dismiss. See United States ex rel. Sequoia Orange Co. v. Baird- Neece Packing Corp., 151 F.3d 1139, 1145 (9th Cir. 1998)(holding that the Government must demonstrate a “valid government purpose” for dismissal and “a rational relation between dismissal and accomplishment of [that] purpose”)(internal citation omitted); see also Ridenour v. Kaiser-Hill Co., L.L.C., 397 F.3d 925, 936 (10th

Cir. 2005) (adopting the “valid government purpose” standard); but see Swift v. United States, 318 F.3d 250, 252 (D.C. Cir. 2003) (reading the statute to give the Government an “unfettered right” to dismiss a qui tam action); Riley v. St. Luke’s Episcopal Hosp., 252 F.3d 749, 753 (5th Cir. 2001) (explaining in dicta that “the government retains the unilateral power to dismiss an action” under section 3730(c)(2)(A)). The First Circuit has not yet formally adopted a standard, although the District of Massachusetts expressed support for the more discretionary standard espoused in Swift. Nasuti ex rel. United States v. Savage Farms, Inc., No. 12-30121-GAO, 2014 WL 1327015 at *1 (D. Mass. Mar. 27, 2014)(adopting the Magistrate Judge’s recommendation and noting that the court finds the “Swift rationale more persuasive” but

declines to formally resolve which standard applies). The Court does not need to decide which standard to adopt today since the Government’s motion would be granted under either standard. See, e.g. Nasuti, 2014 WL 1327015 at *1 (holding that the government’s motion to dismiss should be granted under either standard of review); Chang v. Children’s Advocacy Ctr. of Del., No. 18-2311, 2019 WL 4309516, *2 (3rd Cir. Sept. 12, 2019)(declining to take a side in this circuit split because relator failed “even the more restrictive standard”); AbbVie, 2019 WL 3203000, at *2. Under the stricter standard, the Government has shown at least one “valid government purpose” for dismissing this

action -- the burden this continuing litigation would place on the Government’s resources. See Gov’t Mot. to Dismiss 13-16. For example, Bozilleri’s Complaint alleges, among many other things, “widespread” fraud among all the parties involved in Medicare Part D drug coverage. SAC at ¶33. The Government explained that litigating that allegation alone would necessitate an “inquiry into a wide array of contractual, billing, reporting, and analytical material by means of potentially vast and intrusive discovery that will impact both the United States and third parties.” Gov’t Mot. to Dismiss 14. The Court has no reason to doubt the Government’s contention that further litigation in this action will impose a significant burden on several federal agencies

and take resources away from the administration of parts of the Medicare program. Id. at 15. The Government’s desire not to expend more resources on this lawsuit, especially where it has declined to intervene because it “does not believe that it is in the public interest to pursue this lawsuit,” is a valid and sufficient justification for the Government’s dismissal. Id. at 15; See e.g. Sequoia Orange, 151 F.3d at 1146 (“The district court . . . properly noted that the government can legitimately consider the burden imposed on the taxpayers by its litigation, and that, even if the relators were to litigate the FCA claims, the government would continue to incur enormous internal staff costs.”); Swift, 318 F.3d at 254 (noting

that dismissal would also be proper under Sequoia Orange because the Government’s interest in not “expending resources monitoring the case, complying with discovery requests, and so forth” was “a legitimate objective, and dismissal of the suit furthered that objective.”). Similarly, the Nasuti Court concluded that dismissal was appropriate because of the Government’s concern over incurring “substantial costs in monitoring the litigation, . . . responding to discovery requests, and clarifying Relator’s misstatements of the law.” 2014 WL 1327015, at *11. Despite Bozilleri’s contention to the contrary, the potential merit of his claims does not overcome the Government’s arguments for dismissal. Relator’s Opp’n to United States’ Mot.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Riley v. St Luke's Epis Hosp
252 F.3d 749 (Fifth Circuit, 2001)
Ridenour v. Kaiser-Hill Co.
397 F.3d 925 (Tenth Circuit, 2005)
Swift, Susan v. United States
318 F.3d 250 (D.C. Circuit, 2003)
Rodriguez-Bruno v. Doral Mortgage
57 F.3d 1168 (First Circuit, 1995)
United States Ex Rel. Wickliffe v. EMC Corp.
473 F. App'x 849 (Tenth Circuit, 2012)
United States Ex Rel. Walsh v. Eastman Kodak Co.
98 F. Supp. 2d 141 (D. Massachusetts, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
United States of America, ex rel. v. Bayer AG, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-of-america-ex-rel-v-bayer-ag-rid-2019.